Correlation between alanine aminotransferase level, HCV-RNA titer and fibrosis stage in chronic HCV genotype 4 infection

Egyptian Journal of Medical Human Genetics

Volumn 13, Issue 2, 2012, Pages 207-212

  Al Swaff, Reham ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

ALT; Chronic hepatitis; Fibrosis; Genotype 4; HCV; RNA

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DISEASE SEVERITY; ECHOGRAPHY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY;

HEPATITIS C VIRUS;

EID: 84877042140     PISSN: 11108630     EISSN: 20902441     Source Type: Journal    
DOI: 10.1016/j.ejmhg.2012.03.001     Document Type: Article

References (34)

1. Lee Y.S., Yoon S.K., Chung E.S., et al. The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C. J Korean Med Sci 2001, 16:585-591.
2. Egyptian Ministry of Health. Egyptian Ministry of Health Annual Report, 2007. Available at http://www.mohp.gov.eg/Main.asp.
3. Abdel-Aziz F., Habib M., Mohamed M.K., et al. Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2000, 32:111-115.
4. Seymour C.A. Asymptomatic infection with hepatitis C virus. Br Med J 1994, 308:670-671.
5. Valori R., Christie J. Asymptomatic hepatitis C infection. Be cautious with liver biopsy. Br Med J 1994, 308(6938):1235.
6. Foucher J., Chanteloup E., Vergniol J., et al. Diagnosis of cirrhosis by transient elastography (FibroScan). Gut 2006, 55:403-408.
7. Gretch D., Corey L., Wilson J., et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994, 169:1219-1225.
8. McCormick S.E., Goodman Z.D., Maydonovitch C.L., et al. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 1996, 91:1516-1522.
9. Nousbaum J.B., Pol S., Nalpas B., et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995, 122:161-168.
10. Booth J.C., Foster G.R., Levine T., et al. The relationship of histology to genotype in chronic HCV infection. Liver 1997, 17:144-151.
11. Puoti C., Stati T., Magrini A. Serum HCV RNA titer does not predict the severity of liver damage in HCV carriers with normal aminotransferase levels. Liver 1999, 19:104-109.
12. Chevaliez S., Pawlotsky J.M. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006, 3(2):35-40.
13. Sandrin L., Taner M., Ctheline S., et al. Shear modulus imaging with 2-D transient elastography. IEEE Trans Ultrasoun Ferroelectr Freq Control Soc 2002, 27(12):1261-1268.
14. Vizzutti F., Arena U., Romanelli RG., et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007, 45(5):1290-1297.
15. Adinolfi L.E., Utili R., Andreana A., et al. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig Dis Sci 2001, 46:1677-1683.
16. Zechini B., Pasquazzi C., Aceti A. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression. Eur J Gastroenterol Hepatol 2004, 16:891-896.
17. Puoti C., Magrini A., Stati T., et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997, 26:1393-1398.
18. Liu Pei., Li Ying, Sun Cui-Ming Correlations of serum hepatitis C virus RNA and alanine transaminase with liver histopathological changes in patients with chronic hepatitis C. Lab Med 2009, 40:167-169.
19. Anand B.S., Velez M. Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease. World J Gastroenterol 2004, 10:2409-2411.
20. Bacon B.R. Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology 2002, 36:S179-S184.
21. Sangiovanni A., Morales R., Spinzi G.C., et al. Interferon alfa treatment of HCV carriers with persistently normal transaminase levels. Hepatology 1998, 27:853-856.
22. Calabrese F., Pontisso P., Pettenazzo E., et al. Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels. Hepatology 2000, 31:1153-1159.
23. Kao J.H., Lai M.Y., Chen P.J., et al. Clinical significance of serum hepatitis C virus titer in patients with chronic type C hepatitis. Am J Gastroenterol 1996, 91:506-510.
24. Zeuzem S., Franke A., Lee J.H., et al. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology. Hepatology 1996, 24:1003-1009.
25. Fanning L., Kenny E., Sheehan M., et al. Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogenous population. Hepatology 1999, 29:904-907.
26. Reddy K.R., Messinger D., Popescu M., et al. Peginterferon alpha-2a (40kDa) and ribavirin: comparable rates of sustained virological response in subsets of older and younger HCV genotype 1 patients. J Viral Hepat 2009, 16(10):724-731.
27. Sezaki H., Suzuki F., Kawamura Y., et al. Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads. Dig Dis Sci 2009, 54(6):1317-1324.
28. Khattab M.A., Eslam M. The impact of host factors on management of hepatitis C virus. Hepat Man 2011, 11(8):533-539.
29. Poynard T., Bedossa P., Opolon P., et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997, 349:825-832.
30. Davis K.L., Mitra D., Medjedovic J., et al. Direct economic burden of chronic hepatitis C virus in a United States managed care population. J Clin Gastroenterol 2011, 45(2):e17-e24.
31. Asselah T., Boyer N., Guimont M.C., et al. Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut 2003, 52:1638-1643.
32. Asselah T., Rubbia-Brandt L., Marcellin P., et al. Steatosis in chronic hepatitis C: why does it really matter?. Gut 2006, 55(1):123-130.
33. Moucari R., Asselah T., Cazals-Hatem D., et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008, 134(2):416-423.
34. McCaughan G.W., George J. Fibrosis progression in chronic hepatitis C virus infection. Gut 2004, 53(3):318-321.